Genmab — Juni 2015
-
enig nohope. jeg siger ikke at det ikke kan fejle. Jeg siger bare at hvis det lykkedes så tror jeg stadig vi er konservative i hvor godt det vil lykkes
-
Man kan så vælge at tage gevinst og have en "gratis" portion aktier tilbage.
-
Enig. Desuden er der mange andre gode aktier.
-
Bare se på dem 89 støver op.
-
Ok Nohope.
-
så nohope kan ikke sælge i pensionen for så kan han ikke købe flere og han kan ikke sælge privat for så kommer skattefar
you are stuck with os -
-
Selvom jeg er ekstem risokovillig og bindegal så synes jeg I med god grund kan gøre brug af certifikater. Kommer en forkert meddelelse vil et certifikat tage noget af risikoen i forhold til en aktie. Bortset fra at man ser en ulempe ved lagerbeskatning i forhold til aktiers realisationsbeskatning så er kapitalindkomst rimeligt beskattet. Specielt hvis man har negativ kapitalindkomst.
-
Nu ikke så beskeden Solsen
-
More recently, targeted treatment with oral tyrosine kinase inhibitors has
resulted in dramatic effects; however, these agents are not curative, only
achieve low complete response (CR) rates, have limited long-term safety
data, and resistance has been reported.3,4 They are therefore unlikely to
entirely replace anti-CD20 mAb-based therapy -
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind